PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT02819752 · TERMINATED
Trial details
- NCT number
- NCT02819752
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-12
- Primary completion
- 2019-11-28
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.